Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$TWST Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.56 down -264.71% YoY
• Reported revenue of $118.38M up 23.24% YoY
• Twist Bioscience expects full fiscal year 2026 revenue in the range of $456 million to $457 million and fourth quarter revenue of approximately $123 million to $124 million with adjusted EBITDA breakeven.